Emergent Biosolutions Inc. (EBS) vs Alpha Teknova, Inc. (TKNO)
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
- Alpha Teknova, Inc. TKNO 7.08 −6.84%
Emergent Biosolutions Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $408.0M against $368.1M — 1.1× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against −9.56%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −38.4%) and the higher return on invested capital (−5.27% vs −16.9%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 12 and Alpha Teknova, Inc. on 7.
Valuation
Profitability
| Metric | EBS | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.87% | 34.60% | 53.94% |
| Operating margin | (8.57%) | (36.19%) | 0.00% |
| Net margin | (22.96%) | (38.37%) | 0.00% |
| Free cash flow margin | 11.18% | (16.83%) | 0.00% |
| Return on equity | (40.29%) | (24.19%) | (0.40%) |
| Return on assets | (13.95%) | (16.25%) | (3.32%) |
| Return on invested capital | (5.27%) | (16.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack